Kolon Life Science Inc. (KOSDAQ:102940)
13,170
+790 (6.38%)
Oct 16, 2026, 3:30 PM KST
| Market Cap | 172.40B -55.9% |
| Revenue (ttm) | 211.44B +17.1% |
| Net Income | 34.63B |
| EPS | 2,403.02 |
| Shares Out | 13.09M |
| PE Ratio | 5.48 |
| Forward PE | n/a |
| Dividend | 2.65 (0.02%) |
| Ex-Dividend Date | n/a |
| Volume | 96,046 |
| Open | 12,590 |
| Previous Close | 12,380 |
| Day's Range | 12,470 - 13,500 |
| 52-Week Range | 12,030 - 72,700 |
| Beta | 0.24 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |